Can a diabetes drug shield the heart during a heart attack procedure?
Disease control
Not yet recruiting
This trial tests whether giving empagliflozin before or after a procedure to open a blocked heart artery (primary PCI) reduces heart muscle injury during a heart attack. Adults aged 18-75 of South Asian origin having their first heart attack will be randomly assigned to receive e…
Phase: PHASE2 • Sponsor: Rehman Medical Institute - RMI • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC